Kurs
-5,71%
Kurs
-5,71%
Open
58,00
High
58,00
Low
52,80
Close
52,80
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
1,25 MNOK
Likviditet
1,25 MNOK
Rel. mcap
0,20%
Antal aktier
23 132
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-10 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-05-06 | N/A | Årsstämma |
2025-02-12 | 08:30 | Bokslutskommuniké 2024 |
2024-10-31 | - | Kvartalsrapport 2024-Q3 |
2024-08-29 | - | Kvartalsrapport 2024-Q2 |
2024-04-30 | - | Kvartalsrapport 2024-Q1 |
2024-04-30 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2024-04-29 | - | Årsstämma |
2024-02-09 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | Kvartalsrapport 2023-Q1 |
2023-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2023-05-04 | - | Årsstämma |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-08-25 | - | Kvartalsrapport 2022-Q2 |
2022-05-19 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2022-05-18 | - | Årsstämma |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2021-05-04 | - | Årsstämma |
2021-04-16 | - | Kvartalsrapport 2021-Q1 |
2021-02-11 | - | Bokslutskommuniké 2020 |
2020-10-29 | - | Kvartalsrapport 2020-Q3 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-05-15 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2020-05-14 | - | Årsstämma |
2020-04-24 | - | Kvartalsrapport 2020-Q1 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-21 | - | Extra Bolagsstämma 2019 |
2019-05-10 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2018-07-13 | - | Extra Bolagsstämma 2018 |
2018-06-13 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2018-02-27 | - | Bokslutskommuniké 2017 |
2017-06-06 | - | Årsstämma |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-02-28 12:19:44
Moss, 28 February 2022
Gentian Diagnostics ASA has today been notified that the following transaction
has been completed by a primary insider in Gentian Diagnostics ASA: Tomas
Kramar, board member and primary insider in Gentian Diagnostics ASA, has today
bought 3,636 shares at an average price of NOK 55.94 per share. After the
transaction, Tomas Kramar holds 3,636 shares in Gentian Diagnostics ASA.
Please refer to the attached notification of trading for further details.
This information is subject to the disclosure requirements in the EU Market
Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25